Larotrectinib Sulfate

What Larotrectinib Sulfate Means

Larotrectinib sulfate is a cancer medicine that targets tumors with a specific genetic change called an NTRK gene fusion. This gene fusion creates abnormal proteins known as TRK fusion proteins, which can cause cancer cells to grow and spread. Larotrectinib blocks these TRK proteins, which may help stop or slow down the growth of cancer cells. It is a type of targeted therapy called a tyrosine kinase inhibitor. The drug is also known by other names such as LOXO-101, Trk inhibitor LOXO-101, and the brand name Vitrakvi.

Why Larotrectinib Sulfate Can Matter in Cancer Care

Larotrectinib sulfate is important because it is approved to treat solid tumors that have the NTRK gene fusion, regardless of where the cancer started in the body. This is different from many cancer treatments that focus on the cancer’s location. It is used when tumors have spread or cannot be removed by surgery and when other treatments have not worked or are not suitable. Because it targets a specific genetic change, it may offer a treatment option for patients whose tumors have this rare gene fusion.

What Patients Might See or Hear About Larotrectinib Sulfate

Patients may encounter the term larotrectinib sulfate or its other names—LOXO-101, Trk inhibitor LOXO-101, or Vitrakvi—in medical records, treatment plans, or discussions with their healthcare team. It might be mentioned when discussing test results that show an NTRK gene fusion or when considering treatment options. Because the drug has several names, it can be confusing, so it’s helpful to ask your care team to explain how it relates to your specific cancer and treatment plan.

Where Larotrectinib Sulfate May Appear

This term can appear in various places such as pathology reports, genetic testing results, treatment plans, clinical trial information, or drug information sheets. It may also be referenced in discussions about targeted therapies or personalized cancer treatments. If you see it in your medical documents, it is best to ask your healthcare provider what it means for your care.

What Larotrectinib Sulfate Does Not Automatically Mean

Seeing the term larotrectinib sulfate or its related names does not mean you have a diagnosis or that this drug is definitely part of your treatment. It simply refers to a medication that may be used if your cancer has the specific NTRK gene fusion and meets other criteria. Treatment decisions depend on many factors, so it’s important not to assume the drug is recommended without discussing it with your care team.

Common Questions to Ask Your Care Team

If larotrectinib sulfate comes up in your care, you might ask: Does my cancer have the NTRK gene fusion? Is larotrectinib an option for me? What are the possible benefits and side effects? How does this drug fit with other treatments I’m receiving? Are there clinical trials involving larotrectinib that I could consider? These questions can help you understand how this drug relates to your care.

How to Understand Larotrectinib Sulfate in Context

Because larotrectinib sulfate has several names and is used only for cancers with certain gene changes, it’s important to read it in the context of your medical reports and discussions. Don’t treat the word alone as a diagnosis or treatment plan. Instead, use it as a starting point to talk with your healthcare team about what it means for you personally.

Safety and Next Steps

This information is educational and does not replace medical advice. Larotrectinib sulfate may not be safe or appropriate for everyone. If you see this term in your records or hear it from your care team, the best next step is to ask your healthcare provider to explain how it applies to your specific situation. They can provide guidance about testing, treatment options, and what to expect.